Healthcare -
Biotechnology - NASDAQ - US
$ 313.0
-2.2 %
$ 14.1 B
Market Cap
12.7
P/E
UTHR - SHORT-TERM DEBT
Short-term Debt UTHR - United Therapeutics Corporation
400 M
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
3.54%
10 YEAR CAGR